August 7, 2009 – Using 64-slice CT coronary angiography can avoid further invasive angiographies, which can add up to significant cost savings, according to a new study in the American Journal of Cardiology (August 2009, vol. 104, issue 4, pages 498-500).

Researchers from the Baylor University Medical Center, Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, Texas, said in a real world, clinical setting the negative predictive value of low-risk CTA is very high and exceptionally helpful in predicting freedom from events for up to three years. They said 64-slice CT coronary angiography is being used more often in the evaluation of patients with chest pain and the strength of this test is its high specificity and negative predictive value in exclusion of coronary artery disease (CAD).

However, they say its use remains controversial because there are theoretical risks of radiation, additional costs of the test, and no long-term data to suggest that excluding CAD by use of this test results in positive patient outcomes. A total of 436 patients underwent 64-slice CTA because of chest pain thought to be anginal. Cardiac CT was ordered by the primary physician or cardiologist based on a low to intermediate pretest probability of flow-limiting CAD. A smaller subset of patients initially underwent stress testing but had equivocal findings or continued symptoms that warranted further evaluation.

Of the total patient cohort, 376 had no significant CAD based on CTA results. Of the 60 patients who were believed on CTA to have flow-limiting CAD, 34 (57 percent) ended up having percutaneous coronary intervention or coronary artery bypass grafting. The remaining 26 patients (43 percent) did not have true flow-limiting disease on coronary catheterization and were treated medically. With follow-up of 36 months, all patients with minimal or no disease by CTA were free of events or intervention.

For more information: www.ajconline.org


Related Content

News | Radiology Business

April 23, 2024 — A diverse writing group—lead by authors at the University of Toronto—have developed an approach for ...

Time April 23, 2024
arrow
News | Clinical Trials

April 16, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time April 16, 2024
arrow
News | Mammography

April 12, 2024 — Bayer and Hologic, Inc. announced a first-of-its-kind collaboration to deliver a coordinated solution ...

Time April 12, 2024
arrow
News | Mammography

April 12, 2024 — GE HealthCare, a leader in breast health technology and diagnostics, will feature its latest breast ...

Time April 12, 2024
arrow
News | Radiation Therapy

March 28, 2024 — RefleXion Medical, Inc., a therapeutic oncology company, and Limbus AI, Inc., a provider of software ...

Time March 28, 2024
arrow
News | Artificial Intelligence

March 18, 2024 — RamSoft, a global leader in novel cloud-based RIS/PACS radiology solutions for imaging centers and ...

Time March 18, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Computed Tomography (CT) | By Melinda Taschetta-Millane

Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and ...

Time March 07, 2024
arrow
News | Radiology Imaging

March 5, 2024 — Life Guard Imaging, a pioneering leader in preventative imaging services, is thrilled to announce its ...

Time March 05, 2024
arrow
News | Artificial Intelligence

February 29, 2024 — AIxSCAN, Inc., a Sunnyvale, CA-based developer of a next generation artificial intelligence (AI) ...

Time February 29, 2024
arrow
Subscribe Now